Richard M. Lee‐Ying

505 total citations
49 papers, 299 citations indexed

About

Richard M. Lee‐Ying is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Richard M. Lee‐Ying has authored 49 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Richard M. Lee‐Ying's work include Colorectal Cancer Treatments and Studies (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Prostate Cancer Treatment and Research (11 papers). Richard M. Lee‐Ying is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Prostate Cancer Treatment and Research (11 papers). Richard M. Lee‐Ying collaborates with scholars based in Canada, United States and Egypt. Richard M. Lee‐Ying's co-authors include Winson Y. Cheung, Daniel Y.C. Heng, Safiya Karim, Darren R. Brenner, Renee Lester, Chun Loo Gan, Matthew T. Warkentin, Patricia A. Tang, Vincent C. Tam and Janine M. Davies and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Richard M. Lee‐Ying

44 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard M. Lee‐Ying Canada 10 168 125 78 71 58 49 299
Nicolas Sommer United States 11 260 1.5× 107 0.9× 42 0.5× 74 1.0× 107 1.8× 27 356
B. Killing Germany 7 288 1.7× 141 1.1× 57 0.7× 48 0.7× 51 0.9× 9 329
David Hsiehchen United States 11 210 1.3× 85 0.7× 52 0.7× 107 1.5× 38 0.7× 37 354
Stephanie Yasmin Brule Canada 7 307 1.8× 190 1.5× 77 1.0× 44 0.6× 137 2.4× 18 397
Stefania Di Girolamo Italy 11 147 0.9× 145 1.2× 101 1.3× 86 1.2× 55 0.9× 28 330
Silvia Ruscelli Italy 8 244 1.5× 67 0.5× 50 0.6× 56 0.8× 50 0.9× 15 304
Liberato Di Lullo Italy 10 189 1.1× 110 0.9× 71 0.9× 30 0.4× 30 0.5× 24 321
Katia Dotti Italy 12 364 2.2× 149 1.2× 99 1.3× 58 0.8× 114 2.0× 28 514
Jwa Hoon Kim South Korea 11 182 1.1× 112 0.9× 81 1.0× 75 1.1× 74 1.3× 30 348
Beatrice Borelli Italy 12 435 2.6× 147 1.2× 105 1.3× 73 1.0× 160 2.8× 52 535

Countries citing papers authored by Richard M. Lee‐Ying

Since Specialization
Citations

This map shows the geographic impact of Richard M. Lee‐Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Lee‐Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Lee‐Ying more than expected).

Fields of papers citing papers by Richard M. Lee‐Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard M. Lee‐Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Lee‐Ying. The network helps show where Richard M. Lee‐Ying may publish in the future.

Co-authorship network of co-authors of Richard M. Lee‐Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Lee‐Ying. A scholar is included among the top collaborators of Richard M. Lee‐Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Lee‐Ying. Richard M. Lee‐Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cook, Sarah, Kosuke Takemura, Daniel Yick Chin Heng, et al.. (2024). Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate Cancer. Clinical Genitourinary Cancer. 23(1). 102274–102274. 1 indexed citations
2.
Ko, Jenny J., Lawrence Mbuagbaw, Scott Tyldesley, et al.. (2024). Real-world evaluation of access-driven Canadian treatment sequences in progressive prostate cancer (REACTIVATE). Canadian Urological Association Journal. 18(7). 1 indexed citations
4.
Malone, Shawn, Christopher J.D. Wallis, Richard M. Lee‐Ying, et al.. (2022). Patterns of care for non‐metastatic castration‐resistant prostate cancer: A population‐based study. SHILAP Revista de lepidopterología. 3(5). 383–391. 5 indexed citations
5.
Lee‐Ying, Richard M., Dylan E. O’Sullivan, Nimira Alimohamed, et al.. (2022). Stage migration of testicular germ cell tumours in Alberta, Canada, during the COVID-19 pandemic: a retrospective cohort study. CMAJ Open. 10(3). E633–E642. 2 indexed citations
6.
Lee‐Ying, Richard M., et al.. (2021). Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysis. European Journal of Surgical Oncology. 47(12). 3113–3122. 7 indexed citations
7.
Allen, Michael J., Jennifer J. Knox, Erica S. Tsang, et al.. (2021). Efficacy and safety of lenvatinib in the real-world treatment of hepatocellular carcinoma: Results from a Canadian multicenter database (HCC CHORD).. Journal of Clinical Oncology. 39(3_suppl). 275–275. 3 indexed citations
8.
Lee‐Ying, Richard M., Hao‐Wen Sim, Kelvin Chan, et al.. (2020). Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database. Cancer Medicine. 9(14). 4918–4928. 11 indexed citations
9.
Alimohamed, Nimira, et al.. (2019). Metastasis-free survival as a predictor of overall survival in non-metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 37(7_suppl). 201–201. 6 indexed citations
10.
Lee‐Ying, Richard M., et al.. (2019). An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis. Journal of Gastrointestinal Cancer. 51(1). 280–288. 4 indexed citations
12.
Cheung, Winson Y., Han‐Bo Zhang, Patricia A. Tang, et al.. (2018). A real world multicenter study of first (1L) and second (2L) line treatment patterns and outcomes in advanced pancreatic cancer (APC).. Journal of Clinical Oncology. 36(4_suppl). 476–476. 1 indexed citations
13.
Kim, Christina, Shahid Ahmed, Shahid Ahmed, et al.. (2018). Report from the 19th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Winnipeg, Manitoba; 29–30 September 2017. Current Oncology. 25(4). 275–284. 1 indexed citations
14.
Elser, Christine, et al.. (2018). Oncology Education for Canadian Internal Medicine Residents: The Value of Participating in a Medical Oncology Elective Rotation. Current Oncology. 25(3). 213–218. 4 indexed citations
15.
Sim, Hao‐Wen, Kelvin Chan, Richard M. Lee‐Ying, et al.. (2018). Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database. Cancer Medicine. 7(7). 2816–2825. 14 indexed citations
17.
Lee‐Ying, Richard M., et al.. (2017). Impact of primary tumor sidedness on survival after resection of colorectal liver metastases (CRLM).. Journal of Clinical Oncology. 35(4_suppl). 694–694. 4 indexed citations
18.
Lee‐Ying, Richard M., Brandon Bernard, Gillian Gresham, et al.. (2016). A Comparison of Survival by Site of Metastatic Resection in Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 16(2). e23–e28. 3 indexed citations
19.
Bossé, Dominick, Soundouss Raissouni, Kristopher Dennis, et al.. (2016). PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium. Clinical Colorectal Cancer. 15(3). 243–249. 21 indexed citations
20.
Feng, Xiaolan, Michael Smylie, Tina Cheng, Jose Gerard Monzon, & Richard M. Lee‐Ying. (2014). The impact of clinical response to anti-CTLA4 treatment on overall survival (OS) in metastatic melanoma (MM).. Journal of Clinical Oncology. 32(15_suppl). 9080–9080. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026